14 May 2026
Can Novo Nordisk regain its place in the weight-loss race?Danish healthcare company Novo Nordisk remains one of Europe’s largest companies by market value despite the shares falling 70% over the last two years.
The fall from grace was preceded by a 540% advance in the shares following US regulatory approval for Novo’s diabetes treatment Ozempic in late 2017.
Novo launched the world’s first treatment for...